TGFβ and TNF-mediated osteoclastogenic mechanisms are active in RA, indicating a clinical relevance and presence of TGFβ and TNF-dependent inflammatory osteoclastogenic pathways in RA. Here, TNF is linked to rheumatoid arthritis.